Antioxidative effects of melatonin administration in elderly primary essential hypertension patients
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The imbalance of the redox state of the aging organism may be involved in the development of primary essential hypertension. Melatonin, a potent antioxidant agent, was found to exert a hypotensive effect and improve the function of the cardiovascular system. The aim of this study was to determine the influence of melatonin supplementation on oxidative stress parameters in elderly primary essential hypertensive (EH) patients, controlled by a diuretic (indapamide) monotherapy. The levels of malondialdehyde (MDA) and reduced glutathione (GSH), activities of Cu–Zn superoxide dismutase (SOD‐1), catalase (CAT) and glutathione peroxidase (GSH‐Px) in erythrocytes, the plasma level of nitrate/nitrite, the content of carbonyl groups of plasma proteins and morning melatonin levels in the serum of 17 elderly EH patients were determined at the baseline and after the 15th and 30th days of melatonin supplementation (5 mg daily). Melatonin administration resulted in a significant increase in the morning melatonin concentration, SOD‐1 and CAT activities, and a reduction in the MDA level. Statistically significant alterations in the levels of GSH, nitrate/nitrite and carbonyl groups and the activity of GSH‐Px were not observed. These results indicate an improvement in the antioxidative defense of the organism by melatonin supplementation in the examined group and may suggest melatonin supplementation as an additional treatment supporting hypotensive therapy in elderly EH patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tan, D., Manchester, L. C., Terron, M. P., Flores, L. J., & Reiter, R. J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00407.x · Cited by 1,601 · cited 1×
“[48] suggest that a decrease of blood melatonin level results not from a reduced secretion of the indoleamine by the pineal gland, but, more importantly, from a significant increase in the consumption of melatonin in its reactions with ROS under oxidative stress conditions.”
BackgroundRole of oxidative stress in cardiovascular diseases
Dhalla, N. S., Temsah, R. M., & Netticadan, T. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00002 · Cited by 1,467 · cited 1×
“Moreover, it was found that improvement of the redox status in patients with primary hypertension has beneficial effects [56] and compounds demonstrating antioxidative properties lower the elevated BP [45].”
BackgroundDaily nighttime melatonin reduces blood pressure in male patients with essential hypertension
Scheer, F. A. J. L., Van Montfrans, G. A., van Someren, E. J. W., Mairuhu, G., & Buijs, R. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000113293.15186.3b · Cited by 451
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men
Arangino, S., Cagnacci, A., Angiolucci, M., Vacca, A. M. B., Longu, G., Volpe, A., & Melis, G. B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00112-5 · Cited by 200
Melatonin reduces night blood pressure in patients with nocturnal hypertension
Grossman, E., Laudon, M., Yalcin, R., Zengil, H., Peleg, E., Sharabi, Y., Kamari, Y., Shen-Orr, Z., & Zisapel, N. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.002 · Cited by 168
Prolonged melatonin administration decreases nocturnal blood pressure in women
CAGNACCI, A., CANNOLETTA, M., RENZI, A., BALDASSARI, F., ARANGINO, S., & VOLPE, A. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.05.008 · Cited by 156 · cited 2×
“It was observed that supplementation of melatonin may cause hypoactivity of the sympathetic system by decreasing the level of noradrenaline, which is elevated in patients with nightly hypertension [5].”
BackgroundAcute effects of melatonin administration on cardiovascular autonomic regulation in healthy men
Nishiyama, K., Yasue, H., Moriyama, Y., Tsunoda, R., Ogawa, H., Yoshimura, M., & Kugiyama, K. (2001) · American Heart Journal · doi:10.1067/mhj.2001.114368 · Cited by 113
Influences of melatonin administration on the circulation of women
Cagnacci, A., Arangino, S., Angiolucci, M., Maschio, E., & Melis, G. B. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.2.r335 · Cited by 100
Cited by
Melatonin: Action as antioxidant and potential applications in human disease and aging
Bonnefont-Rousselot, D., & Collin, F. (2010) · Toxicology · doi:10.1016/j.tox.2010.04.008 · Cited by 320
Melatonin: An Established Antioxidant Worthy of Use in Clinical Trials
Korkmaz, A., Reiter, R. J., Topal, T., Manchester, L. C., Oter, S., & Tan, D.-X. (2009) · Molecular Medicine · doi:10.2119/molmed.2008.00117 · Cited by 317
Koziróg, M., Poliwczak, A. R., Duchnowicz, P., Koter-Michalak, M., Sikora, J., & Broncel, M. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00835.x · Cited by 299
“Melatonin administered to patients with hypertension (5 mg/day) increased SOD, CAT, and glutathione reductase activities and reduced malonylodialdehyde (MDA) levels [41].”
BackgroundMelatonin in type 2 diabetes mellitus and obesity
Karamitri, A., & Jockers, R. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0130-1 · Cited by 268
Mesri Alamdari, N., Mahdavi, R., Roshanravan, N., Lotfi Yaghin, N., Ostadrahimi, A., & Faramarzi, E. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1384587 · Cited by 93
Metadata
- Authors
- Kędziora‐Kornatowska, K., Szewczyk‐Golec, K., Czuczejko, J., Pawluk, H., Van Marke de Lumen, K., Kozakiewicz, M., Bartosz, G., & Kędziora, J.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2008-09-12
- Volume
- 45
- Issue
- 3
- Pages
- 312-317
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W1997187974
- Cited by
- 60
- References
- 8
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antioxidative effects of melatonin administration in elderly primary essential hypertension patients. https://app.cochat.ai/papers/10.1111/j.1600-079x.2008.00592.x
- The paper
- Kędziora‐Kornatowska, K., Szewczyk‐Golec, K., Czuczejko, J., Pawluk, H., Van Marke de Lumen, K., Kozakiewicz, M., Bartosz, G., & Kędziora, J. (2008). Antioxidative effects of melatonin administration in elderly primary essential hypertension patients. Journal of Pineal Research. https://doi.org/10.1111/j.1600-079x.2008.00592.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.